Solt DB Invest: Student Access

Student Access is now free. There is no cost.

In fact, earning free lifetime access has a value of $9,000 at our current annual subscription rate over a 40-year investing career.

All students are eligible for Student Access.

We define "student" as participating in any academic program at any level (high school, trade school, community college, undergrad, graduate, medical school, law school, wizardry school, PhD candidates, postdocs, etc.).

You'll annotate at least 250 new entries for the Solt DB Biotech Company Database.

Data are only valuable if they're properly annotated. Unfortunately, no one can accurately track the bioeconomy (or even individual sectors within it) because data aren't standardized, structured, or maintained. Solt DB has developed an intelligent taxonomy to track all biotech sectors in simple, yet granular, language.

We have thousands of companies in unpublished datasets that need to be verified before they can go live. These lists grow every week -- faster than our one-person company can add them. You'll help us annotate companies with the proper data fields using our taxonomy. You'll also have the opportunity to suggest new structures, Tags, and more.

This is a great way to deeply understand the nuances of the bioeconomy and gain insights into dozens of competitive landscapes.

If you annotate 10 companies per month (1-2 hours per month), then it'll take about two years.

This isn't meant to be stressful. Life happens, school happens, exams happen (unfortunately), and internships and co-ops, too. If the finch can assemble an army of students making their best efforts, then we're confident we can capture most of the 10,000+ biotech companies globally within a few years.

Yes!

Although the Solt DB Biotech Company Database is one of our core data assets, we intend to maintain it as a free public resource. Our unique business model is powered by subscriptions to our investment research (what you'll earn for free), which funds our platform and allows us to not squeeze every penny out of people who just want to nerd out about the bioeconomy.